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Abstract
The passive leakage of glucose across bilayers of dimyristoylphosphatidylcholine (DMPC), cholesterol (variable), and
dicetyl phosphate (constant 5.9 mol%) has been measured as efflux over 30 min from multilamellar vesicles. Bilayer
cholesterol was varied from 20 mol% to 40 mol%. Glucose permeation rates were measured from 10‡C to 36‡C, and showed a
maximum in permeability at 24‡C, the DMPC phase transition temperature. Increasing the bilayer cholesterol content above
20 mol% reduced that permeability peak. These results are quite consistent with a large number of similar bilayer
permeability studies over the past 25 years. However, they are not consistent with a previous study of these same systems,
which reported increased glucose permeability with temperature, without any maximum at or near the lipid chain melting
temperature (K. Inoue, Biochim. Biophys. Acta 339 (1974) 390^402). ß 2001 Elsevier Science B.V. All rights reserved.
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It is well known that phospholipid bilayers can
exhibit dramatic changes in permeability to aqueous
solutes near the gel^£uid (chain melting) phase tran-
sition [1^7]. Details of the permeability changes de-
pend, sometimes strongly, on the solute permeants,
the lipids and other components of the bilayer, and
the type of vesicle samples used [1^7]. In almost all
cases, if the phospholipid bilayer undergoes a gel^
£uid phase transition, the bilayer permeability to
both charged and polar aqueous solutes exhibits a
maximum near the phase transition temperature
(Tm). An exception has been reported recently by
Langner and Hui [7], who show signi¢cantly di¡erent
e¡ects on bilayer excess heat capacity and permeabil-
ity for the addition of 5 and 10 mol% stearic acid vs.
oleic acid to unilamellar vesicle preparations of di-
myristoylphosphatidylcholine (DMPC). Another ex-
ception is from Inoue, who reported no maximum,
but instead a monotonic increase with temperature in
glucose permeability of multilamellar vesicles of
DMPC and dipalmitoylphosphatidylcholine (DPPC)
containing various amounts of cholesterol [8].
Several suggested mechanisms for a permeability
maximum near the lipid phase transition have fo-
cused on packing defects in the boundary lipids be-
tween co-existing gel and £uid domains in the bilayer
[1,3,9]. We and others have suggested [2,10^12] that
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increases in permeation and other kinetic e¡ects ob-
served near bilayer phase transitions are due to tran-
sient bilayer defects caused by the dramatic lateral
area (and volume) changes [10,14] produced by lipid
domains as they £uctuate between the gel and £uid
states in dynamic equilibrium. Both mechanisms may
in fact contribute to the increase in permeability near
the phase transition [12]. Fluctuations in area and
volume (and hence density) lead to an increased
lateral compressibility of the bilayer over that of
either the gel or £uid state. Several approaches for
quantifying passive permeability of bilayers in terms
of the enhanced compressibility near Tm have been
reported [4,12^17].
Both experimental and theoretical studies have
suggested that, although the bilayer gel^£uid transi-
tion is substantially ¢rst order, some may be near a
higher order phase transition [11^13]. Such higher
order or continuous phase transitions can occur at
a critical point, well known in liquid^vapor phase
equilibria, and in magnetic systems. A critical point
is the terminus of a two phase coexistence boundary
line on the pressure^temperature phase diagram, be-
low which the line maps the two phase coexistence,
and above which there is no more phase boundary,
hence no phase transition. A bilayer near a critical
point would be expected to exhibit £uctuations on all
length scales, causing dramatic e¡ects in order pa-
rameters and divergent tendencies in response func-
tions such as speci¢c heat and compressibility.
Reliable experimental data for solute permeability
of model and biological membranes are essential for
advancing the understanding of the structure and
function of all membranes. The dramatic anomaly
of the missing permeability maximum [8] is problem-
atic for both theoretical and experimental progress.
Along with the theoretical e¡orts cited above, ap-
plied research studies are underway to examine the
possibilities for using vesicles as drug delivery agents,
with selective permeability as a potential means for
targeting the encapsulated drug for the desired tissue
[18^20].
In this study, the passive permeability of glucose
through fully hydrated DMPC bilayers containing
dicetyl phosphate and cholesterol has been measured
over the temperature range 10^36‡C. Dicetyl phos-
phate, used at low concentration to improve bilayer
stability without noticeable e¡ect on the DMPC
Fig. 1. Percent release over 30 min of trapped glucose from
DMPC MLV, made with 20 mol% cholesterol and 5.9 mol%
dicetyl phosphate, at various incubation temperatures. F,7,
vesicle batches dialyzed below 6‡C and warmed to incubation
temperature; b, vesicle batches dialyzed below 6‡C and used
throughout the temperature range; O, vesicle batches dialyzed
above 34‡C and cooled to incubation temperature.
Fig. 2. Percent of trapped glucose released as a function of
time from DMPC vesicles with 20 mol% cholesterol and
5.9 mol% dicetyl phosphate, while incubated at temperatures of
11‡C (E), 18‡C (R), 24‡C (dialyzed at 6‡C) (b), 24‡C (dialyzed
at 36‡C) (8), 30‡C (F), and 36‡C (a).
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chain melting transition, was held constant at 5.9
mol%, and cholesterol levels varied from 20 mol%
to 40 mol%, allowing comparison with previous re-
ports [8].
DMPC was purchased from Avanti Polar Lipids
(Alabaster, AL), cholesterol, D-glucose, dicetyl phos-
phate and enzymatic glucose assay reagent were pur-
chased from Sigma (St. Louis, MO). The purity of
lipids and cholesterol was veri¢ed by chromatogra-
phy. Bilayer constituents in proper ratios were dis-
solved in chloroform and dried to a uniform thin ¢lm
under reduced pressure by rotary evaporation, then
desiccated under vacuum for at least 4 h to remove
any remaining solvent. Enough 0.3 M aqueous glu-
cose at 40‡C was added to the lipid ¢lm to yield
9.30 nmoles per Wl of suspension, then vortex-agi-
tated 2 or more minutes above 35‡C, producing a
uniform suspension of multilamellar vesicles
(MLV). To remove the external glucose, vesicle sus-
pensions were dialyzed against 0.187 M aqueous
NaCl solution, isosmotic with 0.3 M glucose.
Vesicles with less than 30 mol% cholesterol were dia-
lyzed at 6‡C for at least 8 h, or near 36‡C for at least
3 h to exchange the free glucose for NaCl without
appreciable vesicle leakage or osmotic swelling.
Vesicles with 30 mol% or more cholesterol contained
glucose well at all temperatures, and thus were dia-
lyzed at room temperature for at least 4 h.
Glucose e¥ux from vesicles was determined by
measuring the optical absorbance change with the
reduction of nicotinamide adenine dinucleotide phos-
phate (to NADPH), produced by a hexokinase/glu-
cose-6-phosphate dehydrogenase assay reagent
(Sigma, used at 0.75 of the suggested concentration).
The glucose assay was carried out in 1 cm path
length cuvettes, where the absorbance was measured
at 340 nm in a Spectronic 700 spectrophotometer.
Glucose e¥ux from the MLV, rather than enzyme
in£ux, determined the extent of the assay reaction
due to the size di¡erences of those solute reactants.
Sample temperature was held constant by circulating
thermostatic water through the four-compartment
cuvette holder; the sample temperature was moni-
tored with a thermistor in one of the cuvettes. Du-
plicate experiments were run in parallel in the other
three cuvettes, in one of which the absorbance was
recorded as a function of time. A 10 Wl aliquot of
Fig. 3. Average percent release of trapped glucose from DMPC
MLV containing cholesterol at 25 mol% (b), 30 mol% (7), 35
mol% (O), and 40 mol% (a) over a 30 min period as a func-
tion of temperature. The 25 mol% data are averages of several
samples, either heated from 6‡C or cooled from 36‡C, as in
Fig. 1. Error bars represent the total spread of measurements.
Fig. 4. Average percent release of trapped glucose from DMPC
MLV over 30 min as a function of bilayer cholesterol content.
Incubation temperatures: 11‡C (O) ; 18‡C (E) ; 24‡C (b) ; 30‡C
(7) ; 36‡C (a).
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dialyzed MLV suspension was added to a cuvette
containing 2 ml of the glucose assay reagent. The
initial absorbance at 340 nm was recorded after
5^10 min to measure any untrapped glucose remain-
ing after dialysis. This initial 5^10 min untrapped
glucose assay was carried out at temperatures either
below 10‡C, or above 34‡C, for MLV with less than
30 mol% cholesterol, and at the permeability incuba-
tion temperature for all other preparations. After this
initial untrapped glucose assay, the cuvettes with
vesicle suspensions were brought to the desired tem-
perature in the thermostatic sample chamber and in-
cubated. For comparison with other reports, absor-
bance at 340 nm (assayed glucose e¥ux) was
recorded every 5 min for 30 min total incubation,
su⁄cient time to insure completion of the assay re-
action. Samples were then brought to room temper-
ature and the vesicles were lysed by the addition of 5
Wl of Triton X-100 in chloroform (at least 50% Tri-
ton by volume). Absorbance at 340 nm was mea-
sured after 5 min, giving a measure of the total glu-
cose initially trapped in the MLV, thus allowing
calculation of the percent of trapped glucose released
during the 30 min thermostatic incubation. On sev-
eral occasions, additional Triton X-100 in chloro-
form was added to the cuvette, at least doubling
the amount added, with no signi¢cant additional ab-
sorbance observed.
In order to measure bilayer glucose permeability
for the same MLV preparation throughout the tem-
perature range, in some experiments a 10 Wl sample
of vesicles dialyzed and stored at 6‡C was added to a
glucose assay held at 36‡C and used for the same
measurements as those dialyzed at 36‡C, to deter-
mine leakage rates both below and above 24‡C, the
lipid Tm for DMPC MLV [22]. Vesicles with 20
mol% cholesterol lost as much as half of their
trapped glucose when quickly transferred through
Tm by this method. This glucose leakage was evident
in measurements showing both increased exterior
glucose and lower vesicle containment values. Little
or no glucose was lost upon quickly transferring ali-
quots of MLV with cholesterol levels above 25 mol%
through the lipid Tm.
Vesicles with 20 mol% cholesterol exhibited in-
creased glucose release as the incubation tempera-
tures were raised, approaching Tm from lower tem-
peratures (Fig. 1). Values near 100% release were
sometimes obtained in a 30 min incubation period.
These vesicles also showed increased percent glucose
release as the incubation temperatures were lowered,
approaching Tm from higher temperatures, thus
showing a maximum in bilayer permeability near
the lipid Tm (Fig. 1).
Not surprisingly, the largest spread in data points
due to di¡erent MLV preparations occurred with the
20 mol% cholesterol vesicles (Fig. 1), those most
prone to leakage under any conditions. Results
with vesicle samples from the same preparation
were self-consistent across temperature (Fig. 1).
Some preparations of 20 mol% cholesterol trapped
and/or contained insu⁄cient glucose for further mea-
surements, and those that did contain su⁄cient glu-
cose for these experiments varied in the amount
trapped. Others have experienced similar variations
while determining ion permeability among di¡erent
preparations [1]. Optical absorbance values, mea-
sured after lysing the 20 mol% cholesterol vesicles,
varied from approx. 0.1 to 0.5, under the previously
described assay conditions. Smaller absorbance val-
ues due to incubated leakage were measured in those
samples referred to earlier that were transferred
through Tm prior to the permeability measurements;
the data obtained with these samples correspond to
¢lled circles at and above 24‡C in Fig. 1.
In addition to the variation among preparations,
the addition of Triton X-100 in chloroform used to
lyse the bilayers sometimes had a small but random
e¡ect on the apparent absorbance of the vesicle sam-
ple, due to light scattering. These two variations are
largely responsible for the spread in the 20 mol%
cholesterol data seen in Fig. 1.
The apparent kinetics of glucose leakage from the
various MLV preparations was consistent over the
variety of samples. The shapes of the curves from
0 to 30 min were all relatively similar to those in
Fig. 2, showing the assayed glucose leakage over
time for 20 mol% cholesterol vesicles that were incu-
bated at di¡erent temperatures. The same general
shape of the temperature pro¢le showing a perme-
ability maximum (Fig. 1) would be obtained for any
leakage time interval chosen for comparison (Fig. 2).
In cases where the cuvette and contents were
brought to incubation temperature from below
10‡C, a time lag was evident (Fig. 2). This most
likely corresponds to the time necessary for the cu-
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vette and contents to reach a temperature su⁄cient
for leakage to begin. This time lag is not evident in
samples cooled to incubation temperature from
36‡C. Convenience dictated that samples incubated
at 36‡C to assay untrapped glucose were transferred
via pipet to a cuvette already at the incubation tem-
perature. Thus, these samples reached incubation
temperatures more rapidly than the others.
Vesicles with 25 mol% cholesterol also exhibited
maximum release at 24‡C (Fig. 3). The highest value
observed was 38%, a substantial decrease from the
maximum value near 100% for some of the 20 mol%
cholesterol MLV. Values for percent glucose release
at Tm were obtained by approaching Tm from both
higher and lower temperatures with some samples
from the same MLV preparation, thus giving multi-
ple sets of data for the 25 mol% cholesterol samples
at 24‡C. Vesicles with 30 mol% or more cholesterol
exhibited relatively little glucose leakage at any tem-
perature (Fig. 3).
The e¡ect of bilayer cholesterol content on the
passive release of trapped glucose from these MLV
is summarized in Fig. 4, where the average percent
glucose released at various temperatures is plotted as
a function of cholesterol content. The enhanced re-
lease in the vicinity of 24‡C, and the relatively low
release at temperatures approaching 10‡C or 36‡C
for 20 and 25 mol% cholesterol MLV, show why
dialysis for these samples was carried out at the
speci¢ed temperatures instead of room temperature.
That bilayers with 30 mol% and more cholesterol
required little attention to dialysis and storage tem-
peratures is also evident from the data. One should
not extrapolate this permeability e¡ect of bilayer
cholesterol too far; Corvera et al. have shown that
at low enough levels, cholesterol increases solute per-
meability [17].
The ¢ndings of this study are in agreement with
most studies of bilayer permeability to a wide variety
of ionic and polar aqueous solutes [1^7]. Therefore,
our results for bilayer permeability to glucose do not
agree with the results reported by Inoue [8] for any
of the similar preparations examined here. Vesicle
preparations that exhibit the highly cooperative
gel^£uid phase transition also exhibit a relatively
sharp maximum in aqueous solute permeability at
or near the phase transition temperature. This pat-
tern persists in multicomponent bilayers made with
cholesterol as well as mixtures of di¡erent lipids
[1,2,6,7]. The correlation between permeability max-
ima and phase transitions in lipid bilayers is so
strong that some have suggested using solute perme-
ability to deduce bilayer phase diagrams [23]. The
maximal rate of solute e¥ux near Tm at 20 mol%
cholesterol decreases to the low levels characteristic
of the gel or £uid phase at cholesterol levels near
30 mol% and greater, no doubt due to the decrease
and elimination of the cooperative gel^£uid phase
transition at those same cholesterol levels [22,24].
At temperatures su⁄ciently above and below Tm
(e.g. Tm þ 12‡C in Figs. 1 and 4), there is relatively
little e¥ux of solute at any of the measured choles-
terol levels. The bilayer structural rearrangements
and £uctuations occurring in the thermotropic lipid
chain melting transition are thus most likely respon-
sible for the unusual temperature dependent kinetics
of passive bilayer permeability. Similar kinetic pro-
¢les with temperature that show a clear maximum
near the lipid Tm, and thus can be rationalized
with transient bilayer £uctuations, include phospho-
lipase A2 activity [25,26], protein incorporation into
lipid bilayers [21], as well as other bilayer kinetic
processes [27].
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